Clinical Trials Directory

Trials / Completed

CompletedNCT01658072

Analgesia After Total Hip Arthroplasty: Peri-Articular Injection Versus Epidural Patient Controlled Analgesia (PCA)

Analgesia After Total Hip Arthroplasty: Peri-Articular Injection Versus Epidural Patient Controlled Analgesia

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
90 (actual)
Sponsor
Hospital for Special Surgery, New York · Academic / Other
Sex
All
Age
50 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The best way to provide analgesia after total hip arthroplasty is hotly debated. There are two protocols in use at Hospital for Special Surgery(HSS). Both protocols have their proponents, but there are limited data for making an informed choice of protocols. For total hip arthroplasty at HSS, epidural analgesia is used most frequently as it reduces pain with physical therapy. However, epidural analgesia can be associated with nausea, pruritis, dizziness, and orthostatic hypotension. These side-effects can slow physical therapy and may prolong the time until the patient is ready for discharge. Some surgeons at HSS have decided to use a different analgesic protocol, based on a peri-articular injection. This protocol avoids epidural analgesia and systemic opioids. However, patients are given oral opioids as part of a multimodal pain therapy. The investigators propose to compare peri-articular injection to epidural patient controlled analgesia (Epidural PCA). The investigators will enroll 90 total patients (45 per study arm). The enrollment period will be approximately one year and the duration of the follow-up with study patients will be three months following their procedure.

Conditions

Interventions

TypeNameDescription
PROCEDUREPeri-Articular InjectionUse of a different analgesic protocol, based on a peri-articular injection
PROCEDUREEpidural Patient Controlled Analgesia (Epidural PCA)Epidural analgesia pathway.

Timeline

Start date
2012-02-01
Primary completion
2013-05-01
First posted
2012-08-06
Last updated
2022-04-14
Results posted
2016-05-10

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01658072. Inclusion in this directory is not an endorsement.